Core Viewpoint - The company Hotgen Biotech (688068.SH) announced that its significant associate, Hangzhou Aorui Biotechnology Co., Ltd., has recently obtained a Class III medical device registration certificate in China for a gene methylation detection kit used in the auxiliary diagnosis of suspected primary liver cancer [1] Group 1 - The product name is TSPYL5, RASSF1A, DAB2IP, OTX1, PTPN18, HIST1H3G gene methylation detection kit (PCR fluorescence probe method) [1] - The kit is designed for in vitro qualitative detection of methylated TSPYL5, RASSF1A, DAB2IP, OTX1, PTPN18, HIST1H3G genes in human plasma [1] - The product is applicable for clinical auxiliary diagnosis of suspected primary liver cancer [1]

Core Viewpoint - The company, Hotgen Biotech (688068), announced that its important associate, Aorui Biotech, has recently obtained a Class III medical device registration certificate in China for a gene methylation detection kit, which is used for the auxiliary diagnosis of suspected primary liver cancer [1] Group 1 - The registered product includes TSPYL5, RASSF1A, DAB2IP, OTX1, PTPN18, and HIST1H3G gene methylation detection kits using PCR fluorescence probe method [1] - The product is applicable for clinical auxiliary diagnosis of suspected primary liver cancer [1]